A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

NCT04294472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

BK Virus Infection

Interventions

DRUG: MAU868
OTHER: Placebo

Sponsor

Vera Therapeutics, Inc.